Catalytic method enhances enantioselectivity for S(IV) scaffolds, indicating modular applications in synthesis.
Sulfur plays a pivotal role across diverse fields owing to its distinctive chemical and biological properties, thereby propelling the development of stereoselective synthesis of enantioenriched S(IV)-stereogenic scaffolds. While oxidative strategies for generating S-chiral frameworks have witnessed emerging development, the catalytic reduction of S(VI) species to furnish enantioenriched S(IV) scaffolds remains largely overlooked. Herein, we present an enantioselective catalytic method to access S(IV)-stereogenic sulfinimidate ester scaffolds through a distinct catalytic asymmetric formal reductive transformation of S(VI)-sulfonimidoyl chlorides. Using a naturally occurring, cost-effective quinine organocatalyst, we achieved high enantioselectivity in chiral sulfinimidate ester formation via asymmetric S─O bond formation. The catalyst plays dual critical roles, facilitating both the reduction of S(VI) substrates and the catalytic stereoselective formation of S─O bonds. This approach offers a rapid and efficient pathway to sulfinimidate esters, which serves as versatile intermediates for subsequent modular access to diverse S-chiral sulfilimine and sulfinamidine scaffolds, with promising applications in agrochemical and pharmaceutical discovery.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: